Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitisand asthma in the EGEA study

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 351-360

  Nadif, Rachel ^a   Rava, Marta ^a   Decoster, Brigitte ^b   Huyvaert, Hélène ^b,c   Le Moual, Nicole ^a   Bousquet, Jean ^a,d   Siroux, Valérie ^e,f,g   Varraso, Raphaëlle ^a   Pin, Isabelle ^e,f,g   Zerimech, Farid ^c   Matran, Régis ^b  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e UNIV GRENOBLE ALPES   (France)

^f INSTITUT ALBERT BONNIOT   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; NITRATE; NITRIC OXIDE; NITRITE; BIOLOGICAL MARKER; NITRIC ACID DERIVATIVE;

ADULT; ALLERGY; ARTICLE; ASTHMA; BLOOD LEVEL; BREATH ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL COUNT; EOSINOPHILIA; EXPIRED AIR; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; RHINITIS; SENSITIZATION; CHEMISTRY; CYTOLOGY; EOSINOPHIL; EXHALATION; FORCED EXPIRATORY VOLUME; FRANCE; GENETICS; HYPERSENSITIVITY; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; STATISTICAL MODEL;

ADULT; ALLERGENS; ASTHMA; BIOLOGICAL MARKERS; EOSINOPHILS; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; MODELS, STATISTICAL; NITRATES; NITRIC OXIDE; NITRITES; PHENOTYPE; QUESTIONNAIRES; RHINITIS;

EID: 84905667355     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00202413     Document Type: Article

References (36)

1. Lundberg JO, Weitzberg E. The biological role of nitrate and nitrite: the times they are a-changin'. Nitric Oxide 2010; 22: 61-63.
2. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156-167. (Pubitemid 351194063)
3. Szefler SJ, Wenzel S, Brown R, et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol 2012; 129: S9-S23.
4. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
5. Chérot-Kornobis N, Hulo S, Edmé JL, et al. Analysis of nitrogen oxides (NOx) in the exhaled breath condensate (EBC) of subjects with asthma as a complement to exhaled nitric oxide (FeNO) measurements: a cross-sectional study. BMC Res Notes 2011; 4: 202.
6. Chladkova J, Krcmova I, Chladek J, et al. Validation of nitrite and nitrate measurements in exhaled breath condensate. Respiration 2006; 73: 173-179.
7. Corradi M, Pesci A, Casana R, et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003; 8: 26-30. (Pubitemid 36266700)
8. Dressel H, Müller F, Fischer R, et al. Independent information of nonspecific biomarkers in exhaled breath condensate. Respiration 2010; 80: 401-409.
9. Ganas K, Loukides S, Papatheodorou G, et al. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001; 95: 649-654. (Pubitemid 32785520)
10. Dweik RA, Comhair SA, Gaston B, et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA 2001; 98: 2622-2627. (Pubitemid 32209532)
11. Gratziou C, Rovina N, Makris M, et al. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol 2008; 21: 949-957.
12. Malinovschi A, Pizzimenti S, Sciascia S, et al. Exhaled breath condensate nitrates, but not nitrites or FENO, relate to asthma control. Respir Med 2011; 105: 1007-1013.
13. Nguyen TA, Woo-Park J, Hess M, et al. Assaying all of the nitrogen oxides in breath modifies the interpretation of exhaled nitric oxide. Vascul Pharmacol 2005; 43: 379-384. (Pubitemid 41654718)
14. Ojoo JC, Mulrennan SA, Kastelik JA, et al. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005; 60: 22-26. (Pubitemid 40101013)
15. Rihák V, Zatloukal P, Chládková J, et al. Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis. J Clin Lab Anal 2010; 24: 317-322.
16. Robroeks CMHHT, Van de Kant KDG, Jöbsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy 2007; 37: 1303-1311. (Pubitemid 47372295)
17. Ueno T, Kataoka M, Hirano A, et al. Inflammatory markers in exhaled breath condensate from patients with asthma. Respirology 2008; 13: 654-663. (Pubitemid 351977587)
18. Bouzigon E, Monier F, Boussaha M. Associations between nitric oxide synthase genes and exhaled NO-related phenotypes according to asthma status. PloS One 2012; 7: e36672.
19. Villanueva C, Giulivi C. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic Biol Med 2010; 49: 307-316.
20. Kauffmann F, Dizier MH. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-design issues. EGEA Co-operative Group. Clin Exp Allergy 1995; 25: Suppl. 2, 19-22.
21. Kauffmann F, Dizier MH, Pin I, et al. Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med 1997; 156: S123-S129. (Pubitemid 27449325)
22. Nadif R, Matran R, Maccario J, et al. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol 2010; 104: 385-393.
23. Rava M, Varraso R, Decoster B, et al. Plasma and exhaled breath condensate nitrite-nitrate level in relation to environmental exposures in adults in the EGEA study. Nitric Oxide 2012; 27: 169-175.
24. Lundberg JO, Weitzberg E. NO-synthase independent NO generation in mammals. Biochem Biophys Res Commun 2010; 396: 39-45.
25. Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am 2007; 27: 587-596. (Pubitemid 350051335)
26. Fitzpatrick AM, Brown LAS, Holguin F, et al. Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. J Allergy Clin Immunol 2009; 124: 990-996.
27. Gessner C, Wirtz H. Interleukins and other proteins. In: Horvath I, de Jongste JC, eds. Exhaled Biomarkers. Eur Respir Monogr 2010; 49: 217-230.
28. Nadif R, Decoster B, Huyvaert H, et al. Total nitrate/nitrite levels in plasma and exhaled breath condensate: associations with age and smoking according to asthma among 1159 adults from the EGEA study. Am J Respir Crit Care Med 2010; 181: A3109.
29. ATS Workshop Proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate: executive summary. Am J Respir Crit Care Med 2006; 173: 811-813.
30. Nadif R, Zerimech F, Bouzigon E, et al. The role of eosinophils and basophils in allergic diseases considering genetic findings. Curr Opin Allergy Clin Immunol 2013; 13: 507-513.
31. Diamant Z, Boot JD, Mantzouranis E, et al. Biomarkers in asthma and allergic rhinitis. Pulm Pharmacol Ther 2010; 23: 468-481.
32. Sugiura H, Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide 2011; 25: 138-144.
33. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol 2009; 101: 81-121.
34. Del Pozo V, De Arruda-Chaves E, De Andrés B, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997; 158: 859-864. (Pubitemid 127492664)
35. Iijima H, Duguet A, Eum SY, et al. Nitric oxide and protein nitration are eosinophil dependent in allergenchallenged mice. Am J Respir Crit Care Med 2001; 163: 1233-1240. (Pubitemid 32378465)
36. Erzurum SC, Gaston BM. Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med 2012; 33: 459-471.